Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)

By Zhao X.-Q.   Morse J.S.   Dowdy A.A.   Heise N.   DeAngelis D.   Frohlich J.   Chait A.   Albers J.J.   Brown B.G.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol

By Kanadaşı Mehmet   Çaylı Murat   Demirtaş Mustafa   İnal Tamer   Demir Mesut   Koç Mevlut   Avkaroulları Mahir   Dönmez Yurdaer   Usal Ayhan   Alhan Cumhur C.   Şan Mustafa  

Heart and Vessels, Vol. 21, Iss. 5, 2006-09 ,pp. : 291-297

Springer Publishing Company

Access to resources Recommend Favorite

Evidence on the Protective Role of High-Density Lipoprotein (HDL) in HIV-Infected Individuals

By  

Current Vascular Pharmacology, Vol. 13, Iss. 2, 2015-01 ,pp. : 167-172

Bentham Science Publishers

Access to resources Recommend Favorite

Statins and Metabolism of High Density Lipoprotein

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 215-221

Bentham Science Publishers

Access to resources Recommend Favorite

It's Time to Reassess the High‐Density Lipoprotein (HDL) Hypothesis: CSL112, a Novel Promising Reconstituted HDL Formulation

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite